The ex-dividend date for Shire (Nasdaq:SHPGY) is tomorrow, March 7, 2012. Owners of shares as of market close today will be eligible for a dividend of 38 cents per share. At a price of $103.18 as of 9:30 a.m., the dividend yield is 0.4%.
NEW YORK ( TheStreet) -- The ex-dividend date for Shire (Nasdaq: SHPGY) is tomorrow, March 7, 2012. Owners of shares as of market close today will be eligible for a dividend of 38 cents per share. At a price of $103.18 as of 9:30 a.m. ET, the dividend yield is 0.4%. The average volume for Shire has been 429,700 shares per day over the past 30 days. Shire has a market cap of $18.71 billion and is part of the health care sector and drugs industry. Shares are up 1.6% year to date as of the close of trading on Monday. Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products. It operates in three segments: Specialty Pharmaceuticals, Human Genetic Therapies, and Regenerative Medicine. The company has a P/E ratio of 23.3, below the average drugs industry P/E ratio of 24.4 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Shire as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Shire Ratings Report. See our dividend calendar or top-yielding stocks list.